Da Pang Selected Research

Da Pang Research Topics

Disease

95	Breast Neoplasms (Breast Cancer) 03/2024 - 11/2002
85	Neoplasms (Cancer) 01/2023 - 11/2002
12	Carcinogenesis 01/2023 - 06/2003
12	Lymphatic Metastasis 01/2018 - 05/2011
11	Triple Negative Breast Neoplasms 01/2023 - 01/2013
10	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2011
6	Ductal Carcinoma 01/2020 - 06/2012
3	Breast Diseases (Breast Disease) 01/2023 - 03/2006
3	Fibroadenoma 01/2020 - 06/2003
2	Diarrhea 03/2024 - 03/2021
2	Hypoxia (Hypoxemia) 01/2021 - 01/2018
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020 - 01/2013
2	Neutropenia 01/2020 - 01/2020
2	Esophageal Neoplasms (Esophageal Cancer) 01/2020 - 04/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015 - 01/2015
2	Adenocarcinoma 03/2013 - 01/2011
2	Male Breast Neoplasms (Male Breast Cancer) 11/2012 - 01/2012
2	Stomach Neoplasms (Stomach Cancer) 11/2004 - 04/2004
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Hypersensitivity (Allergy) 10/2022
1	COVID-19 01/2022
1	Melanoma (Melanoma, Malignant) 09/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2021

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 02/2022 - 11/2004
22	Biomarkers (Surrogate Marker)IBA 02/2022 - 03/2006
16	Long Noncoding RNAIBA 02/2023 - 01/2015
14	Messenger RNA (mRNA)IBA 11/2021 - 11/2002
14	Estrogen ReceptorsIBA 01/2018 - 06/2003
12	Progesterone Receptors (Progesterone Receptor)IBA 10/2016 - 02/2010
8	Phenobarbital (Luminal)FDA Link 01/2023 - 01/2013
8	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 07/2013
7	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 09/2012
6	human ERBB2 proteinIBA 01/2021 - 01/2012
5	Hormones (Hormone)IBA 01/2021 - 06/2003
5	MicroRNAs (MicroRNA)IBA 09/2017 - 01/2012
4	Competitive Endogenous RNAIBA 01/2023 - 01/2020
4	Indicators and Reagents (Reagents)IBA 11/2021 - 01/2015
4	LigandsIBA 01/2021 - 01/2013
4	hydrogen sulfite (bisulfite)IBA 01/2021 - 09/2012
4	Hyaluronan ReceptorsIBA 02/2017 - 10/2009
3	pertuzumabIBA 03/2024 - 01/2020
3	AntigensIBA 01/2022 - 09/2021
3	Trastuzumab (Herceptin)FDA Link 03/2021 - 07/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2014
3	CateninsIBA 01/2018 - 09/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 09/2021
2	IronIBA 01/2022 - 01/2019
2	6-methyladenineIBA 01/2022 - 06/2021
2	N-methyladenosineIBA 01/2022 - 06/2021
2	N(4)-chloroacetylcytosine arabinoside (CACA)IBA 01/2022 - 10/2015
2	Cell-Free Nucleic AcidsIBA 08/2021 - 01/2021
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 06/2015
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 01/2018
2	ChromatinIBA 01/2021 - 10/2019
2	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2020
2	Epirubicin (Ellence)FDA LinkGeneric 01/2020 - 07/2015
2	Circulating Tumor DNAIBA 11/2019 - 05/2018
2	Tamoxifen FDA LinkGeneric 01/2019 - 11/2012
2	Histones (Histone)IBA 03/2017 - 01/2017
2	AntibodiesIBA 01/2016 - 04/2014
2	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2015 - 01/2015
2	fangchinoline (limacine)IBA 12/2013 - 01/2011
2	ParaffinIBA 01/2013 - 06/2012
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2012 - 11/2004
2	Actins (F Actin)IBA 06/2003 - 11/2002
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2003 - 11/2002
1	4-amino-5-cyclohexyl-3-hydroxypentanoic acid renin inhibitory peptideIBA 12/2022
1	CytidineIBA 12/2022
1	Histamine Receptors (Histamine Receptor)IBA 10/2022
1	Histamine Antagonists (Antihistamines)IBA 10/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2022
1	Superoxides (Superoxide)IBA 01/2022
1	Lipoxygenase (Lipoxygenase-1)IBA 01/2022
1	IonophoresIBA 01/2022
1	EpitopesIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	UbiquinoneIBA 01/2022
1	Peptide LibraryIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	CopperIBA 01/2022
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2022
1	doramapimodIBA 09/2021
1	Transcription Factors (Transcription Factor)IBA 08/2021
1	Small Nucleolar RNA (snoRNA)IBA 08/2021
1	Protein Kinase CIBA 01/2021
1	Complement C1q (C1q Complement)IBA 01/2021
1	Death Domain ReceptorsIBA 01/2021
1	Ribonucleases (Ribonuclease)IBA 01/2021
1	Ephrin-A4 (Ephrin A4)IBA 01/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2021

Therapy/Procedure

21	Therapeutics 12/2022 - 08/2011
9	Immunotherapy 10/2022 - 01/2016
4	Drug Therapy (Chemotherapy) 09/2021 - 01/2015
2	Neoadjuvant Therapy 01/2020 - 07/2015
2	Mastectomy (Mammectomy) 09/2014 - 06/2013
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Radiotherapy 09/2021
1	Oncolytic Virotherapy 09/2021
1	Biological Therapy 09/2021